ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 2 filers reported holding ANIKA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,024,553 | -36.9% | 860,135 | -12.0% | 0.01% | -37.5% |
| Q2 2023 | $25,405,034 | -9.6% | 977,862 | -0.0% | 0.01% | -11.1% |
| Q1 2023 | $28,096,203 | +98795.5% | 978,300 | +1.9% | 0.01% | +12.5% |
| Q4 2022 | $28,410 | -99.9% | 959,746 | +2.1% | 0.01% | -11.1% |
| Q3 2022 | $22,367,000 | +11.2% | 939,802 | +4.3% | 0.01% | +28.6% |
| Q2 2022 | $20,108,000 | -8.0% | 900,887 | +3.5% | 0.01% | 0.0% |
| Q1 2022 | $21,853,000 | -28.8% | 870,299 | +1.7% | 0.01% | -22.2% |
| Q4 2021 | $30,675,000 | -16.4% | 856,124 | -0.7% | 0.01% | -25.0% |
| Q3 2021 | $36,683,000 | -0.7% | 861,933 | +1.0% | 0.01% | 0.0% |
| Q2 2021 | $36,958,000 | +5.0% | 853,720 | -0.8% | 0.01% | 0.0% |
| Q1 2021 | $35,186,000 | -12.1% | 860,554 | -2.7% | 0.01% | -14.3% |
| Q4 2020 | $40,015,000 | +22.7% | 884,116 | -4.1% | 0.01% | 0.0% |
| Q3 2020 | $32,613,000 | -7.2% | 921,580 | -1.0% | 0.01% | -6.7% |
| Q2 2020 | $35,137,000 | +29.0% | 931,332 | -1.2% | 0.02% | +7.1% |
| Q1 2020 | $27,240,000 | -47.5% | 942,233 | -5.9% | 0.01% | -26.3% |
| Q4 2019 | $51,917,000 | -9.5% | 1,001,294 | -4.2% | 0.02% | -13.6% |
| Q3 2019 | $57,359,000 | +34.6% | 1,044,991 | -0.4% | 0.02% | +29.4% |
| Q2 2019 | $42,622,000 | +37.6% | 1,049,305 | +2.5% | 0.02% | +41.7% |
| Q1 2019 | $30,971,000 | -7.6% | 1,024,179 | +2.7% | 0.01% | -20.0% |
| Q4 2018 | $33,523,000 | -20.3% | 997,441 | -0.0% | 0.02% | -6.2% |
| Q3 2018 | $42,074,000 | +34.5% | 997,485 | +2.0% | 0.02% | +33.3% |
| Q2 2018 | $31,282,000 | -32.4% | 977,569 | +5.0% | 0.01% | -36.8% |
| Q1 2018 | $46,278,000 | -4.8% | 930,771 | +3.3% | 0.02% | -5.0% |
| Q4 2017 | $48,589,000 | -6.5% | 901,304 | +0.6% | 0.02% | -13.0% |
| Q3 2017 | $51,945,000 | +19.9% | 895,600 | +2.0% | 0.02% | +15.0% |
| Q2 2017 | $43,321,000 | +29.2% | 878,006 | +13.8% | 0.02% | +25.0% |
| Q1 2017 | $33,522,000 | -6.4% | 771,699 | +5.5% | 0.02% | -11.1% |
| Q4 2016 | $35,823,000 | +2.6% | 731,679 | +0.2% | 0.02% | -5.3% |
| Q3 2016 | $34,926,000 | -13.0% | 729,924 | -2.4% | 0.02% | -17.4% |
| Q2 2016 | $40,134,000 | +14.9% | 748,083 | -4.2% | 0.02% | +9.5% |
| Q1 2016 | $34,935,000 | +18.1% | 781,196 | +0.8% | 0.02% | +16.7% |
| Q4 2015 | $29,575,000 | +26.6% | 775,025 | +5.6% | 0.02% | +20.0% |
| Q3 2015 | $23,359,000 | -1.6% | 733,870 | +2.1% | 0.02% | 0.0% |
| Q2 2015 | $23,750,000 | -18.9% | 719,061 | +1.1% | 0.02% | -16.7% |
| Q1 2015 | $29,281,000 | -10.5% | 711,225 | -11.4% | 0.02% | -14.3% |
| Q4 2014 | $32,717,000 | -6.0% | 803,068 | -15.4% | 0.02% | -16.0% |
| Q3 2014 | $34,789,000 | -21.1% | 948,932 | -0.2% | 0.02% | -19.4% |
| Q2 2014 | $44,066,000 | +15.2% | 951,130 | +2.2% | 0.03% | +6.9% |
| Q1 2014 | $38,242,000 | +9.3% | 930,486 | +1.5% | 0.03% | +7.4% |
| Q4 2013 | $34,980,000 | +66.1% | 916,678 | +4.3% | 0.03% | +50.0% |
| Q3 2013 | $21,057,000 | +47.7% | 878,814 | +4.8% | 0.02% | +38.5% |
| Q2 2013 | $14,258,000 | – | 838,712 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
| Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
| DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
| Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
| Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
| Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
| Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
| BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
| Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
| Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |